NDC 63629-8909-01 - PRAVASTATIN SODIUM
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63629-8909
- Requested NDC
- 63629-8909-01
- Package NDCs from labels
- 63629-8909-1, 63629-8909-01
- Manufacturer
- Bryant Ranch Prepack
- Effective date
- 2025-04-22
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| PRAVASTATIN SODIUM - Bryant Ranch Prepack | Bryant Ranch Prepack | 2025-04-22 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63629-8909-1 | PRAVASTATIN SODIUM | 1000 in 1 BOTTLE | TABLET | 1000 | 105 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63629-8909 | PRAVASTATIN SODIUM TABLET [BRYANT RANCH PREPACK] | 105 | Current NDC, Legacy NDC, 1 package rows | 20250424_0bb2f1e8-9405-4f06-9a33-5ba06765a8e7.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63629-8909-1 | EA - Each | 63629-8909 | 3b1b57c4-29b8-4cce-aca1-6174f79bfb01 | 1 | 2022-01-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Vitrexyl | FOLIC ACID | PureTek Corporation | ae064a9e-daba-fa86-e053-2a95a90a16a7 | 2023-01-11 | Warnings, Adverse reactions | 3A3U0GI71G |
| Vitranol Fe | FERROUS FUMARATE, FOLIC ACID | PureTek Corporation | b81daf17-430b-6ba2-e053-2a95a90a768b | 2023-01-11 | Warnings, Adverse reactions | 3A3U0GI71G |
| Vitrexate | FOLIC ACID | PureTek Corporation | b34fee43-bea9-45b7-e053-2a95a90aad4d | 2023-01-11 | Warnings, Adverse reactions | 3A3U0GI71G |
| Vitrexate FE | FERROUS FUMARATE, FOLIC ACID | PureTek Corporation | b3637def-a701-673a-e053-2995a90a02d5 | 2023-01-11 | Warnings, Adverse reactions | 3A3U0GI71G |
| Venexa | FOLIC ACID | PureTek Corporation | ba130779-cdfd-086d-e053-2a95a90a2590 | 2023-01-11 | Warnings, Adverse reactions | 3A3U0GI71G |
| Venexa FE | FERROUS FUMARATE, FOLIC ACID | PureTek Corporation | ba142128-21c4-4204-e053-2a95a90ae0d7 | 2023-01-11 | Warnings, Adverse reactions | 3A3U0GI71G |
| Ribotin-E | FERROUS FUMARATE, FOLIC ACID | PureTek Corporation | bb1492c5-bfcd-d632-e053-2a95a90ad7d1 | 2023-01-11 | Warnings, Adverse reactions | 3A3U0GI71G |
| Ventrixyl Fe | FERROUS FUMARATE, FOLIC ACID | PureTek Corporation | c7a626ec-88ec-d899-e053-2a95a90ab0ba | 2023-01-11 | Warnings, Adverse reactions | 3A3U0GI71G |
| Zintrexyl-C | FERROUS FUMARATE, FOLIC ACID | PureTek Corporation | bb1492c5-bfca-d632-e053-2a95a90ad7d1 | 2023-01-11 | Warnings, Adverse reactions | 3A3U0GI71G |
| Magnesia Oxydata | MAGNESIA OXYDATA | Hahnemann Laboratories, INC. | e45bc2b0-72f4-42e1-e053-2995a90a0e66 | 2022-07-21 | 3A3U0GI71G | |
| Pravastatin Sodium | PRAVASTATIN SODIUM | Glenmark Pharmaceuticals Inc., USA | 6ca01de3-a0f9-4cfb-b36a-723c7c42e2a4 | 2022-07-08 | Warnings, Adverse reactions | 904458 904481 904467 904475 3M8608UQ61 |
| Pravastatin Sodium | PRAVASTATIN SODIUM | Teva Pharmaceuticals, Inc. | f66cb1c1-5ff1-4b0b-89d0-8ecaee26b0b8 | 2022-07-01 | Warnings, Adverse reactions | 904481 3M8608UQ61 |
| PRAVASTATIN SODIUM | PRAVASTATIN SODIUM | Aphena Pharma Solutions - Tennessee, LLC | ce61f570-2564-429b-8775-157e8e32d378 | 2022-03-03 | Warnings, Adverse reactions | 904481 3M8608UQ61 |
| PRAVASTATIN SODIUM | PRAVASTATIN SODIUM | Proficient Rx LP | 2bdfb0ef-2455-4ca2-a117-ce8e26bb2dbc | 2022-03-01 | Warnings, Adverse reactions | 904475 3M8608UQ61 |
| Magnesium Oxide | MAGNESIUM OXIDE | Par Health | d5c123f8-1396-4d8c-96d3-e5ade96a6ef8 | 2020-11-10 | Warnings | 3A3U0GI71G |
| Magnesium Oxide | MAGNESIUM OXIDE | Par Health | d3c5b01b-f0d6-4503-ab18-b1a72386e2c6 | 2020-06-03 | Warnings | 3A3U0GI71G |
| PRAVASTATIN SODIUM | PRAVASTATIN SODIUM | Proficient Rx LP | 63ca6179-6ae3-4f0b-bdca-50d200317921 | 2019-10-01 | Warnings, Adverse reactions | 904475 3M8608UQ61 |
| Magnesium Oxide 400mg | MAGNESIUM OXIDE 400MG | Allegiant Health | 2ea68874-8c20-4284-bd0a-f07768057b83 | 2019-01-28 | Warnings | 3A3U0GI71G |
| Pravastatin sodium | PRAVASTATIN SODIUM | Dr.Reddy's Laboratories Limited | 99cc0546-bb2d-751e-edfd-1c15a1182e0c | 2018-11-21 | Warnings, Adverse reactions | 904458 904481 904467 904475 3M8608UQ61 |
| Magnesium Oxide | MAGNESIUM OXIDE | Aphena Pharma Solutions - Tennessee, LLC | 11b2ce71-61fd-4e75-a859-a260b1dda080 | 2018-11-07 | Warnings | 3A3U0GI71G |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.